Thelium Therapeutics is an early-stage preclinical company that develops agents to restore the intestinal barriers in inflammatory diseases.
Thelium Therapeutics has raised $18.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2022.
Thelium Therapeutics is headquartered in San Carlos, United States.
Thelium Therapeutics is an early-stage preclinical company that develops agents to restore the intestinal barriers in inflammatory diseases.
Thelium Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Thelium Therapeutics — Funding & Investors." VCBacked, May 5, 2022, https://www.vcbacked.co/company/thelium-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Thelium Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/thelium-therapeutics
{{cite web |title=Thelium Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/thelium-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated